Perspective Therapeutics, Inc. (CATX) stock
CATXNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$0.75−0.03 (-3.85%)
Close on Nov 20, 2026Market cap $86.05MP/E –Yield –
Perspective Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Perspective Therapeutics's total assets was $392.03M at Jun 30, 2026. For fiscal 2025 it was $266.97M, down 21.7% from the year before. Over ten years it grew 26.0% a year on average. The highest annual figure on record is $341.10M in fiscal 2024.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $266.97M | -21.7% |
| FY2024 | Dec 31, 2024 | $341.10M | +429.3% |
| FY2022 | Jun 30, 2022 | $64.44M | -8.5% |
| FY2021 | Jun 30, 2021 | $70.42M | +709.5% |
| FY2020 | Jun 30, 2020 | $8.70M | -7.7% |
| FY2019 | Jun 30, 2019 | $9.42M | +26.4% |
| FY2018 | Jun 30, 2018 | $7.46M | -39.2% |
| FY2017 | Jun 30, 2017 | $12.27M | -32.2% |
| FY2016 | Jun 30, 2016 | $18.10M | -21.3% |
| FY2015 | Jun 30, 2015 | $23.00M | -13.4% |
| FY2014 | Jun 30, 2014 | $26.55M | +276.3% |
| FY2013 | Jun 30, 2013 | $7.06M | -6.0% |
| FY2012 | Jun 30, 2012 | $7.51M | -4.9% |
| FY2011 | Jun 30, 2011 | $7.89M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $392.03M | +26.2% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $410.77M | +24.7% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $266.97M | -21.7% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $294.83M | -24.6% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $310.73M | -19.5% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $329.35M | +18.3% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $341.10M | +429.3% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $391.15M | +491.6% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $385.92M | +473.8% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $278.29M | +305.0% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $64.44M | -8.5% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $66.11M | -7.2% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $67.25M | +333.5% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $68.71M | +756.2% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $70.42M | +709.5% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $71.28M | +695.4% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $15.51M | +73.7% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $8.03M | -20.7% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $8.70M | -7.7% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $8.96M | -15.3% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $8.93M | -25.0% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $10.12M | -24.1% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $9.42M | +26.4% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $10.58M | +27.1% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $11.91M | +27.0% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $13.34M | +23.8% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $7.46M | -39.2% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $8.32M | -40.3% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $9.38M | -37.4% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $10.78M | -35.4% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $12.27M | -32.2% |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $13.94M | -29.6% |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $14.99M | -27.8% |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $16.69M | -23.8% |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | $18.10M | -21.3% |
| Q3 FY2016CQ1 2016 | Mar 31, 2016 | $19.80M | -16.1% |
| Q2 FY2016CQ4 2015 | Dec 31, 2015 | $20.74M | – |
| Q1 FY2016CQ3 2015 | Sep 30, 2015 | $21.91M | – |
| Q4 FY2015CQ2 2015 | Jun 30, 2015 | $23.00M | – |
| Q3 FY2015CQ1 2015 | Mar 31, 2015 | $23.58M | – |
See a number that looks wrong?